|Articles|August 1, 2002

Developing New Drugs in 1000 Days

Everybody wants faster cycles and and quicker turnarounds with NDAs. In the U.S., will it soon be possible to go from testing to approval in 1000 days?

Articles in this issue

about 23 years ago

Article

Cross-(Dys)Functional Teams

about 23 years ago

Article

eSource Redux

about 23 years ago

Article

Paper vs. Electronic Diaries

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.